ESMO Sarcoma & Rare Cancers Congress 2026 — Lugano, Switzerland

This dedicated oncology meeting will focus on the latest scientific advancements, clinical trial data, and innovative strategies in the diagnosis and treatment of sarcomas and other rare cancers — areas that closely align with EURACAN’s mission to improve care and outcomes for patients with rare adult solid tumors.

Highlights of the congress include multidisciplinary discussions on:

• Novel diagnostic approaches and molecular characterization of rare cancers
• Insights from cutting-edge clinical and translational research
• Updates on precision therapeutics and targeted treatment strategies
• Collaborative sessions that foster networking across expert centres and advocacy groups
  These exchanges are designed to accelerate progress in rare cancer management and support knowledge sharing across clinical and research communities.

The event continues ESMO’s long-standing commitment to education and clinical excellence in oncology. As a network of expert centres for rare adult solid cancers, EURACAN looks forward to engaging with ESMO colleagues and participants at this important congress to further strengthen collaborative efforts in research, clinical care models, and guideline development for rare cancers.

Detailed programme information and registration can be found on the official ESMO congress calendar.